Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001055711 | SCV001220115 | uncertain significance | Holocarboxylase synthetase deficiency | 2022-04-10 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 709 of the HLCS protein (p.Pro709Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with holocarboxylase synthetase deficiency (PMID: 27604308). ClinVar contains an entry for this variant (Variation ID: 851334). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HLCS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001055711 | SCV004199829 | likely pathogenic | Holocarboxylase synthetase deficiency | 2023-11-23 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001055711 | SCV002095586 | uncertain significance | Holocarboxylase synthetase deficiency | 2020-08-16 | no assertion criteria provided | clinical testing |